Market Cap 618.78M
Revenue (ttm) 875.26M
Net Income (ttm) 70.79M
EPS (ttm) N/A
PE Ratio 9.89
Forward PE N/A
Profit Margin 8.09%
Debt to Equity Ratio 0.10
Volume 150,200
Avg Vol 206,190
Day's Range N/A - N/A
Shares Out 6.97M
Stochastic %K 15%
Beta 0.03
Analysts Strong Sell
Price Target $248.33

Company Profile

Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultraso...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 713 660 0557
Fax: 832 787 1278
Address:
1776 Yorktown Street, Suite 700, Houston, United States
ripster47
ripster47 Mar. 12 at 5:06 AM
$NUTX long trade setup after earnings! 📈 Game plan shared with members for both sides - short under 78 or if 78 holds, long on 5/12 curls. Market gave us the 5/12 curl! Thanks to @ripster47 for all-day guidance on $NUTX long trade 🎯
0 · Reply
Trade_the_plan
Trade_the_plan Mar. 11 at 4:18 PM
$NUTX give me one more time below $80 for a swing
0 · Reply
EMILYXCap
EMILYXCap Mar. 10 at 9:24 AM
$NUTX low float healthcare setup, if buyers press this can become a real squeeze candidate
0 · Reply
Doozio
Doozio Mar. 9 at 11:25 PM
The ole MNDY 🐑 low $LIND zon. Yo see how $NUTX if got premarket on FRYday? 🐒🍌🧠⏰♾️
0 · Reply
Doozio
Doozio Mar. 9 at 7:59 PM
This volatility is $NUTX YO. 🐒🍌🧠⏰♾️
0 · Reply
marmcd_fx
marmcd_fx Mar. 9 at 3:51 PM
$NUTX low float healthcare setup, if volume expands this has the
0 · Reply
Teachme123
Teachme123 Mar. 8 at 5:21 AM
$NUTX I found their explanations and answers to the odd bits of the report quite reasonable. I was never expecting a smooth revenue curve with the IDR process being such a key part of the story. However since it was shown that the IDR payments are in line (or even lower) than in-network rates(Washington post link below), I don’t expect any additional write offs that would cause any major change over the long run. And even if revenue becomes lower than I expect, their cash generating ability and profitability is so strong that they most likely have room to cope with it. The in-network rates that they are negotiating is encouraging as well. I would rather take slightly lower, but more dependable, revenues (and not have to pay high fees for the IDR). I’m also expecting the bipartisan supported “no surprises enforcement act” to pass soon, which should immediately solve the any cash collection uncertainty and give more leverage when negotiating in-network rates.
3 · Reply
GTradewell
GTradewell Mar. 7 at 5:55 PM
$NUTX should spike back up to 120ish in very short order.
1 · Reply
smallmidcaps
smallmidcaps Mar. 7 at 2:06 PM
$NUTX i hope im wrong. i did fully exit my position yesterday at a loss. i felt tricked about the revenue miss. i knew the rev/visit metric was too high but i didn’t expect it to be this bad. the stock is going to $70 imo. interestingly, the A/R went up by 50 mln if you add back the true-up and the 2024 q3 adjustment. Sounds like the aggressive revenue recognition was part of the play to convince shareholders to allow dilution. it worked. this buyback program barely makes a dent in the total share count. More A/R write offs are coming given that the average rev per visit was $5700 in 2025 q3 and the A/R remains large. They aren’t able to collect this much money from insurers who fight back and delay and sue HaloMD, etc. Good luck to shareholders.
3 · Reply
HTNY
HTNY Mar. 7 at 11:48 AM
Earnings season has been handy so far. $DAVE did what i expected - and, in fairness, what they told you in advance - but the financing power play afterwards sustained the move with real strength. Three other plays that worked well were all ones where Algos and retail forgot to read below the fold and just based their reaction on the topline number without seeing the wood for the trees. $INSG - bought at 8.6-9.2 and sold at 12 $DUOL - bought at 91 and sold at 102 $NUTX - had a starter at 105, bought more below 80 and much more at 70-71 and sold at 92. My strategy in these plays is to retain 50% of profit as free shares. That way you protect capital, realize profit and ensure some participation in future upside. You can then rotate gains into thematic plays that you like longer term and wait for conviction plays to deploy meaningful capital. This is a market that will continue to offer significant overreactions in both directions.
1 · Reply
Latest News on NUTX
Nutex Health Inc. (NUTX) Q4 2025 Earnings Call Transcript

Mar 6, 2026, 5:45 PM EST - 9 days ago

Nutex Health Inc. (NUTX) Q4 2025 Earnings Call Transcript


NUTEX HEALTH RE-OPENS BAYOU CITY ER & HOSPITAL IN HOUSTON

Jan 12, 2026, 5:30 AM EST - 2 months ago

NUTEX HEALTH RE-OPENS BAYOU CITY ER & HOSPITAL IN HOUSTON


NUTEX HEALTH OPENS ARCHVIEW ER & HOSPITAL IN ST. LOUIS

Dec 22, 2025, 5:30 AM EST - 2 months ago

NUTEX HEALTH OPENS ARCHVIEW ER & HOSPITAL IN ST. LOUIS


NUTEX HEALTH EXTENDS SHARE REPURCHASE PLAN

Dec 4, 2025, 5:30 AM EST - 3 months ago

NUTEX HEALTH EXTENDS SHARE REPURCHASE PLAN


NUTEX HEALTH RESPONDS TO SHORT SELLER REPORT

Nov 26, 2025, 4:10 PM EST - 3 months ago

NUTEX HEALTH RESPONDS TO SHORT SELLER REPORT


NUTEX HEALTH REOPENS RED RIVER ER & HOSPITAL IN TEXAS

Nov 24, 2025, 4:38 PM EST - 3 months ago

NUTEX HEALTH REOPENS RED RIVER ER & HOSPITAL IN TEXAS


NUTEX HEALTH REPORTS RESTATED 2024 FINANCIAL RESULTS

Nov 18, 2025, 6:26 PM EST - 4 months ago

NUTEX HEALTH REPORTS RESTATED 2024 FINANCIAL RESULTS


NUTEX HEALTH PROVIDES CORPORATE UPDATE

Oct 20, 2025, 5:30 AM EDT - 5 months ago

NUTEX HEALTH PROVIDES CORPORATE UPDATE


ripster47
ripster47 Mar. 12 at 5:06 AM
$NUTX long trade setup after earnings! 📈 Game plan shared with members for both sides - short under 78 or if 78 holds, long on 5/12 curls. Market gave us the 5/12 curl! Thanks to @ripster47 for all-day guidance on $NUTX long trade 🎯
0 · Reply
Trade_the_plan
Trade_the_plan Mar. 11 at 4:18 PM
$NUTX give me one more time below $80 for a swing
0 · Reply
EMILYXCap
EMILYXCap Mar. 10 at 9:24 AM
$NUTX low float healthcare setup, if buyers press this can become a real squeeze candidate
0 · Reply
Doozio
Doozio Mar. 9 at 11:25 PM
The ole MNDY 🐑 low $LIND zon. Yo see how $NUTX if got premarket on FRYday? 🐒🍌🧠⏰♾️
0 · Reply
Doozio
Doozio Mar. 9 at 7:59 PM
This volatility is $NUTX YO. 🐒🍌🧠⏰♾️
0 · Reply
marmcd_fx
marmcd_fx Mar. 9 at 3:51 PM
$NUTX low float healthcare setup, if volume expands this has the
0 · Reply
Teachme123
Teachme123 Mar. 8 at 5:21 AM
$NUTX I found their explanations and answers to the odd bits of the report quite reasonable. I was never expecting a smooth revenue curve with the IDR process being such a key part of the story. However since it was shown that the IDR payments are in line (or even lower) than in-network rates(Washington post link below), I don’t expect any additional write offs that would cause any major change over the long run. And even if revenue becomes lower than I expect, their cash generating ability and profitability is so strong that they most likely have room to cope with it. The in-network rates that they are negotiating is encouraging as well. I would rather take slightly lower, but more dependable, revenues (and not have to pay high fees for the IDR). I’m also expecting the bipartisan supported “no surprises enforcement act” to pass soon, which should immediately solve the any cash collection uncertainty and give more leverage when negotiating in-network rates.
3 · Reply
GTradewell
GTradewell Mar. 7 at 5:55 PM
$NUTX should spike back up to 120ish in very short order.
1 · Reply
smallmidcaps
smallmidcaps Mar. 7 at 2:06 PM
$NUTX i hope im wrong. i did fully exit my position yesterday at a loss. i felt tricked about the revenue miss. i knew the rev/visit metric was too high but i didn’t expect it to be this bad. the stock is going to $70 imo. interestingly, the A/R went up by 50 mln if you add back the true-up and the 2024 q3 adjustment. Sounds like the aggressive revenue recognition was part of the play to convince shareholders to allow dilution. it worked. this buyback program barely makes a dent in the total share count. More A/R write offs are coming given that the average rev per visit was $5700 in 2025 q3 and the A/R remains large. They aren’t able to collect this much money from insurers who fight back and delay and sue HaloMD, etc. Good luck to shareholders.
3 · Reply
HTNY
HTNY Mar. 7 at 11:48 AM
Earnings season has been handy so far. $DAVE did what i expected - and, in fairness, what they told you in advance - but the financing power play afterwards sustained the move with real strength. Three other plays that worked well were all ones where Algos and retail forgot to read below the fold and just based their reaction on the topline number without seeing the wood for the trees. $INSG - bought at 8.6-9.2 and sold at 12 $DUOL - bought at 91 and sold at 102 $NUTX - had a starter at 105, bought more below 80 and much more at 70-71 and sold at 92. My strategy in these plays is to retain 50% of profit as free shares. That way you protect capital, realize profit and ensure some participation in future upside. You can then rotate gains into thematic plays that you like longer term and wait for conviction plays to deploy meaningful capital. This is a market that will continue to offer significant overreactions in both directions.
1 · Reply
King_of_Bio
King_of_Bio Mar. 6 at 9:44 PM
$NUTX Any new investors getting in during that drop...lucky lol
0 · Reply
3fbee
3fbee Mar. 6 at 6:18 PM
$NUTX I averaged up from $18 to $25. Thanks for the drop :-)
0 · Reply
Hodlingon
Hodlingon Mar. 6 at 5:46 PM
$NUTX congrats to those who bought yesterday after hours at $70. I follow 3 day rule as it has served me well over time, so didn't purchase, but I do think after hours yesterday was a massive overreaction and I would be surprised if it hits those levels again. If it does I am buying. Their hospitals have extremely positive reviews which is impressive.
0 · Reply
ronennagar
ronennagar Mar. 6 at 4:34 PM
0 · Reply
Trade_the_plan
Trade_the_plan Mar. 6 at 4:19 PM
$NUTX thank you for below $80. SUPER gift
0 · Reply
HTNY
HTNY Mar. 6 at 4:07 PM
$NUTX Had to drop off the call but this thing is going to be just fine.
0 · Reply
WenABVEAudit
WenABVEAudit Mar. 6 at 3:48 PM
$NUTX very solid call so far 💪
0 · Reply
HTNY
HTNY Mar. 6 at 3:18 PM
$NUTX Nice.
0 · Reply
BullJack
BullJack Mar. 6 at 3:15 PM
$NUTX damn bough 20 shares at 74.95. Wish I wasn’t such a 🐱 and bought more.
0 · Reply
jgaeth
jgaeth Mar. 6 at 2:40 PM
$NUTX now dont screw up the call and send us back to 70
0 · Reply
WenABVEAudit
WenABVEAudit Mar. 6 at 2:38 PM
$NUTX wow… faster road to recovery than some may have been anticipating. Seems like this stock is heavily manipulated
0 · Reply
DonCorleone77
DonCorleone77 Mar. 6 at 2:13 PM
$MRVL $IOT $NUTX $DAWN $ASPI PRE-MARKET MOVERS: Currently Higher After Earnings: - Genesco (GCO) up 15.0% - Marvell (MRVL) up 9.5% - Samsara (IOT) up 7.7% - MarketWise (MKTW) up 15.4% - Guidewire (GWRE) up 2.1% Currently Also Higher: - Day One Pharmaceuticals (DAWN) up 65.3% after Servier agrees to them for $21.50 per share in cash Currently Lower After Earnings: - Nutex Health (NUTX) down 23.7% - Owlet (OWLT) down 23.7% - Gap (GAP) down 10.3% - Embraer (EMBJ) down 4.6% - Algonquin Power (AQN) down 3.3% Currently Also Lower: - Western Alliance (WAL) and Jefferies (JEF) down 12.1% and 5.1%, respectively, after Jefferies said that payments of $126.4M owed to Western Alliance Bank pursuant to a forbearance agreement will not be paid as agreed - ASP Isotopes (ASPI) down 2.2% after announcing Quantum Leap enters MOU with the U.S. energy company
1 · Reply